224 related articles for article (PubMed ID: 28405549)
1. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study.
Keen MA; Shah IH; Sheikh G
Indian Dermatol Online J; 2017; 8(2):104-110. PubMed ID: 28405549
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Skin Changes with Hormonal Changes in Polycystic Ovarian Syndrome: A Cross-sectional Study Clinical Study.
Gowri BV; Chandravathi PL; Sindhu PS; Naidu KS
Indian J Dermatol; 2015; 60(4):419. PubMed ID: 26288423
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestation of polycystic ovary syndrome.
Abusailik MA; Muhanna AM; Almuhisen AA; Alhasanat AM; Alshamaseen AM; Bani Mustafa SM; Nawaiseh MB
Dermatol Reports; 2021 Aug; 13(2):8799. PubMed ID: 34659671
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
7. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS).
Artar G; Tas B; Turan G; Uckan HH
Gynecol Endocrinol; 2022 Dec; 38(12):1104-1108. PubMed ID: 36579834
[TBL] [Abstract][Full Text] [Related]
9. Dermatologic manifestations of polycystic ovary syndrome.
Lee AT; Zane LT
Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center.
Aljefri YE; Alahmadi RA; Alajmi RS; Alkhamisi TA; Maaddawi HA; Alraddadi AA; Alamri AM
Cureus; 2021 Dec; 13(12):e20593. PubMed ID: 35103169
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
Lowenstein EJ
Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and acne.
Chuan SS; Chang RJ
Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome: a dermatologic approach.
Moura HH; Costa DL; Bagatin E; Sodré CT; Manela-Azulay M
An Bras Dermatol; 2011; 86(1):111-9. PubMed ID: 21437531
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Cutaneous Manifestations with Body Mass Index, Blood Glucose, and Hormonal Levels in Patients with Polycystic Ovarian Disease.
Sharma YK; Chauhan S; Singh P; Deo K
Indian Dermatol Online J; 2020; 11(3):378-381. PubMed ID: 32695697
[TBL] [Abstract][Full Text] [Related]
16. Dermatologic manifestation of hyperandrogenism: a retrospective chart review.
Clark CM; Rudolph J; Gerber DA; Glick S; Shalita AR; Lowenstein EJ
Skinmed; 2014; 12(2):84-8. PubMed ID: 24933845
[TBL] [Abstract][Full Text] [Related]
17. [Hyperandrogenism, adrenal dysfunction, and hirsutism].
Makrantonaki E; Zouboulis CC
Hautarzt; 2020 Oct; 71(10):752-761. PubMed ID: 32857168
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Cutaneous Manifestations With Body Mass Index (BMI) in Polycystic Ovary Syndrome (PCOS) Patients in a Tertiary Care Centre: An Observational Study.
Jena P; Tiwari M; Panda SR; Samantroy S; Panda J
Cureus; 2021 Dec; 13(12):e20695. PubMed ID: 35106232
[TBL] [Abstract][Full Text] [Related]
19. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
20. Acne - a potential skin marker of internal disease.
Pace JL
Clin Dermatol; 2015; 33(5):572-8. PubMed ID: 26321405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
